Altered p53 is associated with aggressive behavior of chondrosarcoma: a long term follow-up study.Oshiro Y., Chaturvedi V., Hayden D., Nazeer T., Johnson M., Johnston D.A., Ordonez N.G., Ayala A.G., Czerniak B.View abstractAnnotationAssociated with PSYCH: aggressive behavior of chondrosarcoma.CategoriesDisease & VariantsSourceGAD:137193PubMedEurope PMCCancer 83:2324-2334 (1998)Mapped to99+
Loss of p53 gene mutation after irradiation is associated with increased aggressiveness in recurring head and neck cancer.Gallo O., Chiarelli I., Bianchi S., Calzolari A., Simonetti L., Porfirio B.View abstractAnnotationAssociated with CANCER: increased aggressiveness.CategoriesDisease & VariantsSourceGAD:137174PubMedEurope PMCClin Cancer Res 2:1577-1582 (1996)Mapped to99+
Association of p53 mutations with metastatic prostate cancer.Eastham J.A., Stapleton A.M., Gousse A.E., Timme T.L., Yang G., Slawin K.M., Wheeler T.M., Scardino P.T., Thompson T.C.View abstractAnnotationAssociated with CANCER: prostate cancer.CategoriesDisease & VariantsSourceGAD:137199PubMedEurope PMCClin Cancer Res 1:1111-1118 (1995)Mapped to99+
Hepatitis C virus infection associated with human hepatocellular carcinoma: lack of correlation with p53 abnormalities in Caucasian patients.Pontisso P., Belluco C., Bertorelle R., De Moliner L., Chieco-Bianchi L., Nitti D., Lise M., Alberti A.View abstractAnnotationNot Associated with CANCER: Hepatitis C virus infection associated with human hepatocellular carcinoma.CategoriesDisease & VariantsSourceGAD:137141PubMedEurope PMCCancer 83:1489-1494 (1998)Mapped to99+
Characteristics of mutations in the p53 gene of oral squamous-cell carcinomas associated with betel-quid chewing in Sri Lanka.Chiba I., Muthumala M., Yamazaki Y., Uz Zaman A., Iizuka T., Amemiya A., Shibata T., Kashiwazaki H., Sugiura C., Fukuda H.View abstractAnnotationAssociated with CANCER: betel-quid chewing.CategoriesDisease & VariantsSourceGAD:137191PubMedEurope PMCInt J Cancer 77:839-842 (1998)Mapped to99+
In oesophageal squamous cell carcinoma vascular endothelial growth factor is associated with p53 mutation, advanced stage and poor prognosis.Uchida S., Shimada Y., Watanabe G., Tanaka H., Shibagaki I., Miyahara T., Ishigami S., Imamura M.View abstractAnnotationAssociated with CANCER: oesophageal squamous cell carcinoma.CategoriesDisease & VariantsSourceGAD:137195PubMedEurope PMCBr J Cancer 77:1704-1709 (1998)Mapped to99+
Association between p53 mutation and clinicopathological features of non- small cell lung cancer.Guang S.G., Ogura T., Sekine I., Yokozaki M., Esumi H., Kodama T., Nagai K.View abstractAnnotationAssociated with CANCER: Lung cancer.CategoriesDisease & VariantsSourceGAD:137123PubMedEurope PMCJpn J Clin Oncol 27:211-215 (1997)Mapped to99+
dic(5;17): a recurring abnormality in malignant myeloid disorders associated with mutations of TP53.Wang P., Spielberger R.T., Thangavelu M., Zhao N., Davis E.M., Iannantuoni K., Larson R.A., Le Beau M.M.View abstractAnnotationAssociated with OTHER: malignant myeloid disorders.CategoriesDisease & VariantsSourceGAD:137175PubMedEurope PMCGenes Chromosomes Cancer 20:282-291 (1997)Mapped to99+
Association of p53 gene mutation with decreased chemosensitivity in human malignant gliomas.Iwadate Y., Fujimoto S., Tagawa M., Namba H., Sueyoshi K., Hirose M., Sakiyama S.View abstractAnnotationAssociated with OTHER: decreased chemosensitivity.CategoriesDisease & VariantsSourceGAD:137147PubMedEurope PMCInt J Cancer 69:236-240 (1996)Mapped to99+
Association of low CYP3A activity with p53 mutation and CYP2D6 activity with Rb mutation in human bladder cancer.Romkes M., Chern H.D., Lesnick T.G., Becich M.J., Persad R., Smith P., Branch R.A.View abstractAnnotationAssociated with CANCER: bladder cancer.CategoriesDisease & VariantsSourceGAD:137151PubMedEurope PMCCarcinogenesis 17:1057-1062 (1996)Mapped to99+
Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.Perego P., Giarola M., Righetti S.C., Supino R., Caserini C., Delia D., Pierotti M.A., Miyashita T., Reed J.C., Zunino F.View abstractAnnotationAssociated with CANCER: ovarian carcinoma.CategoriesDisease & VariantsSourceGAD:137125PubMedEurope PMCCancer Res 56:556-562 (1996)Mapped to99+
The accumulation of p53 abnormalities is associated with progression of mucosa-associated lymphoid tissue lymphoma.Du M., Peng H., Singh N., Isaacson P.G., Pan L.View abstractAnnotationAssociated with CANCER: mucosa-associated lymphoid tissue lymphoma.CategoriesDisease & VariantsSourceGAD:137138PubMedEurope PMCBlood 86:4587-4593 (1995)Mapped to99+
Mutations in the P53 and RAS family genes are associated with tumor progression of BCR/ABL negative chronic myeloproliferative disorders.Gaidano G., Guerrasio A., Serra A., Carozzi F., Cambrin G.R., Petroni D., Saglio G.View abstractAnnotationAssociated with CANCER: tumor progression of BCR/ABL negative chronic myeloproliferative disorders.CategoriesDisease & VariantsSourceGAD:137182PubMedEurope PMCLeukemia 7:946-953 (1993)Mapped to99+
Association of p53 mutations with short survival in colorectal cancer.Hamelin R., Laurent-Puig P., Olschwang S., Jego N., Asselain B., Remvikos Y., Girodet J., Salmon R.J., Thomas G.View abstractAnnotationAssociated with CANCER: colorectal cancer.CategoriesDisease & VariantsSourceGAD:137162PubMedEurope PMCGastroenterology 106:42-48 (1994)Mapped to99+
Infrequency of MDM2 gene amplification in pediatric solid tumors and lack of association with p53 mutations in adult squamous cell carcinomas.Waber P.G., Chen J., Nisen P.D.View abstractAnnotationNot Associated with CANCER: adult squamous cell carcinoma.CategoriesDisease & VariantsSourceGAD:137198PubMedEurope PMCCancer Res 53:6028-6030 (1993)Mapped to99+
Association of immunohistochemical staining for p53 with metastatic progression and poor survival in patients with renal cell carcinoma.Uhlman D.L., Nguyen P.L., Manivel J.C., Aeppli D., Resnick J.M., Fraley E.E., Zhang G., Niehans G.A.View abstractAnnotationAssociated with CANCER: metastatic progression and poor survival.CategoriesDisease & VariantsSourceGAD:137136PubMedEurope PMCJ Natl Cancer Inst 86:1470-1475 (1994)Mapped to99+
The association of p53 immunopositivity with tumor proliferation and other prognostic indicators in breast cancer.Bhargava V., Thor A., Deng G., Ljung B.M., Moore D.H., Waldman F., Benz C., Goodson W., Mayall B., Chew K.View abstractAnnotationAssociated with CANCER: tumor proliferation and other prognostic indicators.CategoriesDisease & VariantsSourceGAD:137130PubMedEurope PMCMod Pathol 7:361-368 (1994)Mapped to99+
Accumulation of p53 is associated with tumour progression in cutaneous lesions of renal allograft recipients.Stark L.A., Arends M.J., McLaren K.M., Benton E.C., Shahidullah H., Hunter J.A., Bird C.C.View abstractAnnotationAssociated with CANCER: tumour progression.CategoriesDisease & VariantsSourceGAD:137132PubMedEurope PMCBr J Cancer 70:662-667 (1994)Mapped to99+
Racial disparity in the association of p53 gene alterations with breast cancer survival.Shiao Y.H., Chen V.W., Scheer W.D., Wu X.C., Correa P.View abstractAnnotationAssociated with CANCER: breast cancer survival.CategoriesDisease & VariantsSourceGAD:137196PubMedEurope PMCCancer Res 55:1485-1490 (1995)Mapped to99+
Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck.Brennan J.A., Boyle J.O., Koch W.M., Goodman S.N., Hruban R.H., Eby Y.J., Couch M.J., Forastiere A.A., Sidransky D.View abstractAnnotationAssociated with CANCER: smoking.CategoriesDisease & VariantsSourceGAD:137164PubMedEurope PMCN Engl J Med 332:712-717 (1995)Mapped to99+
Association of p53 gene mutations with short survival in pancreatic adenocarcinoma.Nakamori S., Yashima K., Murakami Y., Ishikawa O., Ohigashi H., Imaoka S., Yaegashi S., Konishi Y., Sekiya T.View abstractAnnotationAssociated with CANCER: pancreatic adenocarcinoma.CategoriesDisease & VariantsSourceGAD:137161PubMedEurope PMCJpn J Cancer Res 86:174-181 (1995)Mapped to99+
Association of p53 gene and protein alterations with metastases in colorectal cancer.Bertorelle R., Esposito G., Del Mistro A., Belluco C., Nitti D., Lise M., Chieco-Bianchi L.View abstractAnnotationAssociated with CANCER: metastases.CategoriesDisease & VariantsSourceGAD:137135PubMedEurope PMCAm J Surg Pathol 19:463-471 (1995)Mapped to99+
Recent aflatoxin exposure and mutation at codon 249 of the human p53 gene: lack of association.Hsieh D.P., Atkinson D.N.View abstractAnnotationNot Associated with OTHER: aflatoxin exposure.CategoriesDisease & VariantsSourceGAD:137210PubMedEurope PMCFood Addit Contam 12:421-424 (1995)Mapped to99+
Constitutional p53 mutations associated with brain tumors in young adults.Chen P., Iavarone A., Fick J., Edwards M., Prados M., Israel M.A.View abstractAnnotationAssociated with CANCER: brain tumors.CategoriesDisease & VariantsSourceGAD:137150PubMedEurope PMCCancer Genet Cytogenet 82:106-115 (1995)Mapped to99+
Cellular immortality: a late event in the progression of human squamous cell carcinoma of the head and neck associated with p53 alteration and a high frequency of allele loss.Edington K.G., Loughran O.P., Berry I.J., Parkinson E.K.View abstractAnnotationAssociated with CANCER: squamous cell carcinoma.CategoriesDisease & VariantsSourceGAD:137197PubMedEurope PMCMol Carcinog 13:254-265 (1995)Mapped to99+